spacer
home > ebr > spring 2019 > the road to success
PUBLICATIONS
European Biopharmaceutical Review

The Road to Success

When thinking of biomarkers and their role in delivering personalised medicine, most will picture recent advances in oncology and, in particular, those that have arisen following seminal developments in human genomics, including the publishing of the human genome sequence in 1999. However, in reality, biomarkers have been around for much longer and have been driving a move to a more personalised approach to medicine for many years. This article examines both historical and modern groundbreaking examples to explain and exemplify the different types of biomarkers and their use in medicine.

Defining Biomarkers

There are many definitions of biomarkers, but this article will focus on one from a WHO collaborative study which defined a biomarker as “any substance, structure, or process that can be measured in the body or its products and influence or predict the incidence of outcome or disease” (1). If this definition is extended to include the effects of treatments, interventions, and exposure to environmental agents such as chemicals or nutrients, the possibilities are endless.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Dr Karen Hills is Director of Marketing and Medical Affairs at PredictImmune, focussing on the launch of new products and clinical studies. Her background includes medical and marketing roles in both startup companies and Big Pharma. Karen has a PhD from the University of Cambridge and an Executive MBA from London Business School, UK.

Professor Ken Smith is Professor of Medicine and Head of the Department of Medicine at the University of Cambridge and is Chief Medical Officer at PredictImmune. He trained in nephrology and clinical immunology and completed a PhD at the Walter and Eliza Hall Institute of Medical Research in Melbourne, Australia. His lab runs a translational programme in autoimmune disease (particularly IBD, vasculitis, and SLE) that has led to the discovery of a novel prognosis-predicting biomarker currently in clinical trials and the identification of genes and pathways involved in disease pathogenesis.
spacer
Dr Karen Hills
spacer
spacer
spacer
Professor Ken Smith
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Cambridge Sensotec (manufacturers of Dynascan) obtains new ISO accreditation

On the 30th May 2019, Cambridge Sensotec proudly achieved ISO 9001:2015 accreditation under the BSI (British Standards Institution). Cambridge Sensotec Ltd now joins 1.3 million companies across 112 countries worldwide that hold this prestigious certificate.
More info >>

White Papers

Recommendations Sourcing Human Biospecimens

BioIVT

The foundations for protecting human research subjects come from the ethical principles surrounding the Belmont report : Respect for persons, beneficence, and justice. The use of human biospecimens in research supports these principles with legal and ethical regulations - the most important of which is permission.(1) This permission may come directly from the donor or granted by others with authorization to protect the interests of biospecimen donors.
More info >>

 
Industry Events

World Vaccine Congress Europe

28-31 October 2019, Barcelona, Spain

The 20th annual World Vaccine Congress Europe is taking place 28-31 Oct in Barcelona. It’s the biggest and most established European vaccine event with over 250 speakers, 700+ senior vaccine attendees, hundreds of networking hours. It cover key topics across the complete vaccine value chain bringing together: • Government • big pharma • big biotech • SME Biotech • academia and the wider service provider community and their partners to discuss scientific, clinical and strategic advances and opportunities. The event has already confirmed over 200 speakers from Human Vaccine Project, OECD, CEPI, European Commission, FDA, WHO, OECD, NIH, GSK and many more… There is a Super Early Bird offer available – Find Out More www.terrapinn.com/WVCEU/EBR
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement